Deposition of mouse amyloid β in human APP/PS1 double and single AD model transgenic mice
- 30 September 2006
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 23 (3) , 653-662
- https://doi.org/10.1016/j.nbd.2006.05.010
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Mouse models of Alzheimer's disease: insight into treatment.Reviews in the Neurosciences, 2004
- The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer’s diseaseNeuroscience, 2001
- The Presenilins in Alzheimer's Disease--Proteolysis Holds the KeyScience, 1999
- Characterization of New Polyclonal Antibodies Specific for 40 and 42 Amino Acid-Long Amyloid β Peptides: Their Use to Examine the Cell Biology of Presenilins and the Immunohistochemistry of Sporadic Alzheimer’s Disease and Cerebral Amyloid Angiopathy CasesMolecular Medicine, 1997
- Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: a possible role for apolipoprotein E in Alzheimer's diseaseBrain Research, 1997
- Proteolytical processing of mutated human amyloid precursor protein in transgenic miceMolecular Brain Research, 1997
- A vector for expressing foreign genes in the brains and hearts of transgenic miceGenetic Analysis: Biomolecular Engineering, 1996
- Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In VivoNeuron, 1996
- ßPP Participates in PrP-Amyloid Plaques of Gerstmann-Sträussler-Scheinker Disease, Indiana KindredJournal of Neuropathology and Experimental Neurology, 1993
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991